Biotech Chromatin Bioscience’s synthetic promoter supports EsoBiotec’s ESO-T01 CAR-T therapy as it enters the clinic January 18, 2025
Biotech Mission Therapeutics announces publication in Nature Reviews Drug Discovery of article highlighting how neurodegenerative diseases can be tackled by enhancing mitophagy January 15, 2025
Biotech FDA accepts Biologics License Application for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US January 15, 2025
Biotech Xeltis announces completion of enrolment in EU Pivotal Trial for aXess and prepares for market approval January 7, 2025
Biotech Asieris and CDC Sign Investigational Product Supply Agreement for APL-1202 in Free-Living Amoeba Infections Treatment under Expanded Access Investigational New Drug Program January 6, 2025
Biotech WILLOW ANNOUNCES CANCELLATION OF PREVIOUSLY ANNOUNCED NON-BROKERED OFFERING TO PURSUE LESS DILUTIVE ALTERNATIVES January 4, 2025
Biotech Optimizing Outsourcing: A Case Study on Evaluating CDMO Capabilities for API and FD Development January 3, 2025
Biotech Fapon Biopharma Introduces FP008 at Biotech Showcase: A Safer and More Effective Immunotherapy for Refractory Cancers January 2, 2025